AI Article Synopsis

  • A whole exome sequencing study identified a de novo mutation (p.Ile52Thr) in the PMP2 gene of a patient with Charcot-Marie-Tooth disease type 1, which was also present in his affected son, correlating with demyelinating neuropathy.
  • Another family with Charcot-Marie-Tooth disease type 1 was found to have a different mutation (p.Thr51Pro) in PMP2, further establishing the genetic link.
  • The findings indicate that dominant mutations in the PMP2 gene are responsible for Charcot-Marie-Tooth disease type 1.

Article Abstract

We performed whole exome sequencing on a patient with Charcot-Marie-Tooth disease type 1 and identified a de novo mutation in PMP2, the gene that encodes the myelin P2 protein. This mutation (p.Ile52Thr) was passed from the proband to his one affected son, and segregates with clinical and electrophysiological evidence of demyelinating neuropathy. We then screened a cohort of 136 European probands with uncharacterized genetic cause of Charcot-Marie-Tooth disease and identified another family with Charcot-Marie-Tooth disease type 1 that has a mutation affecting an adjacent amino acid (p.Thr51Pro), which segregates with disease. Our genetic and clinical findings in these kindred demonstrate that dominant PMP2 mutations cause Charcot-Marie-Tooth disease type 1.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022672PMC
http://dx.doi.org/10.1093/brain/aww055DOI Listing

Publication Analysis

Top Keywords

charcot-marie-tooth disease
20
disease type
12
pmp2 mutations
8
disease
6
charcot-marie-tooth
5
novo pmp2
4
mutations families
4
type
4
families type
4
type charcot-marie-tooth
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!